抗磷脂综合征的临床管理

冯莹. 抗磷脂综合征的临床管理[J]. 临床血液学杂志, 2017, 30(1): 8-11. doi: 10.13201/j.issn.1004-2806.2017.01.003
引用本文: 冯莹. 抗磷脂综合征的临床管理[J]. 临床血液学杂志, 2017, 30(1): 8-11. doi: 10.13201/j.issn.1004-2806.2017.01.003
FENG Ying. Clinical management of antiphospholipid syndrome[J]. J Clin Hematol, 2017, 30(1): 8-11. doi: 10.13201/j.issn.1004-2806.2017.01.003
Citation: FENG Ying. Clinical management of antiphospholipid syndrome[J]. J Clin Hematol, 2017, 30(1): 8-11. doi: 10.13201/j.issn.1004-2806.2017.01.003

抗磷脂综合征的临床管理

详细信息
    通讯作者: 冯莹,E-mail:fyzlply@163.com
  • 中图分类号: R554

Clinical management of antiphospholipid syndrome

More Information
  • 加载中
  • [1]

    Baker WF Jr,Bick RL,Fareed J.Controversies and unresolved issues in antiphospholipid syndrome pathogenesis and management[J].Hematol Onclo Clin North Am,2008,22:155-174.

    [2]

    Galli M,Ruggeri L,Barbui T.Differential effects of anti-beta 2-glycoprotein I and antiprothrombin antibodics on the anticoagulant activity of antivated protein C[J].Blood,1998,91:1999-2004.

    [3]

    Giannakopoulos B,Krilis SA.The pathogenesis of the antiphospholipid syndrome[J].N Engl J Med,2013,368:1033-1044.

    [4]

    陈晓微,申艳,孙传银,等.抗磷脂综合征174例临床特点及与欧洲数据的比较分析[J].中华风湿病学杂志,2010,14(6):394-397.

    [5]

    李茹,周云杉,贾园,等.抗磷脂综合征患者血栓事件的危险因素分析[J].北京大学学报,2012,44(5):788-791.

    [6]

    谭立夫,邱茜,梁柳琴,等.抗磷脂综合征55例临床分析[J].实用医学杂志,2011,27(15):2789-2791.

    [7]

    张悦,朱德生,管阳太.抗磷脂综合征18例临床分析[J].中国神经免疫性和神经病学杂志,2013,20(3):156-159.

    [8]

    许蕊苡,赵伟,胡红,等.抗磷脂综合征57例临床分析[J].解放军医学院院报,2014,35(6):541-544.

    [9]

    冷晓梅,刘晓敏,艾脉兴,等.抗磷脂综合征61例临床分析[J].中华医学杂志,2004,84(16):1367-1370.

    [10]

    吴庆军,朱燕林,唐福林,等.抗磷脂综合征100例临床特征分析[J].中华风湿病学杂志,2007,11(11):675-678.

    [11]

    徐娜,张尧,张文,等.抗磷脂综合征165例临床特征与分型[J].中华内科杂志,2009,48(11):904-907.

    [12]

    徐瑞焱,高瑞通,郭立琳,等.抗磷脂抗体综合征合并急性心肌梗死10例分析[J].中国心血管病杂志,2010,15(2):113-115.

    [13]

    Cervera R,Piette JC,Font J,et al.Antiphospholipid syndrome:clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients[J].Arthritis Rheum,2002,46:1019-1027.

    [14]

    Miyakis S,Lockshin MD,Atsumi T,et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)[J].J Thromb Haemost,2006,4:295-306.

    [15]

    Gardiner C,Hills J,Machin SJ,et al.Diagnosis of antiphospholipid syndrome in routine clinical practice[J].Lupus,2013,22:18-25.

    [16]

    Donnan PT,Mcdonald MJ.Patients experiences of a diagnosis of Hughes' syndrome[J].Clin Rheumatol,2009,28:1091-1100.

    [17]

    Asherson RA,Cervera R,Groot PG,et al.Catastrophic antiphospholipid syndrome:international consensus statement on classification criteria and treatment guidelines[J].Lopus,2003,12:530-534.

    [18]

    Kitchens CS.Thrombotic storm:when thrombosis begets thrombosis[J].J Am Med,1998,104:381-385.

    [19]

    Sciascia S,Lopez-Pedrera C,Roccatello D,et al.Catastrophic antiphospholipid syndrome (CAPS)[J].Best Pract Res Clin Rheumatol,2012,26:535-541.

    [20]

    Aguiar CL,Erkan D.Catastrophic antiphospholipid syndrome:how to diagnose a rare but highly fatal disease[J].Ther Adv Musculoskelet Dis,2013,5:305-314.

  • 加载中
计量
  • 文章访问数:  30
  • PDF下载数:  20
  • 施引文献:  0
出版历程
收稿日期:  2016-11-21

目录